Cargando…
Vitamin D, Gut Microbiota, and Cardiometabolic Diseases—A Possible Three-Way Axis
Metabolic syndrome (MetSyn) is a precursor for several cardiometabolic diseases such as obesity, type-2 diabetes mellitus (T2DM), and cardiovascular diseases. Emerging evidence suggests that vitamin D deficiency links to cardiometabolic diseases through microbiota. A combination of poor vitamin D st...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866669/ https://www.ncbi.nlm.nih.gov/pubmed/36674452 http://dx.doi.org/10.3390/ijms24020940 |
_version_ | 1784876149083471872 |
---|---|
author | Sukik, Ayah Alalwani, Joud Ganji, Vijay |
author_facet | Sukik, Ayah Alalwani, Joud Ganji, Vijay |
author_sort | Sukik, Ayah |
collection | PubMed |
description | Metabolic syndrome (MetSyn) is a precursor for several cardiometabolic diseases such as obesity, type-2 diabetes mellitus (T2DM), and cardiovascular diseases. Emerging evidence suggests that vitamin D deficiency links to cardiometabolic diseases through microbiota. A combination of poor vitamin D status and dysbiosis may contribute to the progression of cardiometabolic diseases. Therefore, in this review, we present the relationship among vitamin D, microbiota, and cardiometabolic diseases with a focus on MetSyn. We searched major databases for reports on vitamin D, microbiota, and MetSyn until June 2022. We reviewed 13 reports on the relation between vitamin D and MetSyn (6 randomized controlled and 7 cross-sectional studies) and 6 reports on the effect of vitamin D on the gut microbiome. Adequate vitamin D status has a beneficial effect on gut microbiota, therefore preventing the progression of MetSyn. Further, well-controlled studies are needed for a better understanding of the mechanisms of action involving vitamin D and microbiota in the pathogenesis of cardiometabolic diseases. |
format | Online Article Text |
id | pubmed-9866669 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98666692023-01-22 Vitamin D, Gut Microbiota, and Cardiometabolic Diseases—A Possible Three-Way Axis Sukik, Ayah Alalwani, Joud Ganji, Vijay Int J Mol Sci Review Metabolic syndrome (MetSyn) is a precursor for several cardiometabolic diseases such as obesity, type-2 diabetes mellitus (T2DM), and cardiovascular diseases. Emerging evidence suggests that vitamin D deficiency links to cardiometabolic diseases through microbiota. A combination of poor vitamin D status and dysbiosis may contribute to the progression of cardiometabolic diseases. Therefore, in this review, we present the relationship among vitamin D, microbiota, and cardiometabolic diseases with a focus on MetSyn. We searched major databases for reports on vitamin D, microbiota, and MetSyn until June 2022. We reviewed 13 reports on the relation between vitamin D and MetSyn (6 randomized controlled and 7 cross-sectional studies) and 6 reports on the effect of vitamin D on the gut microbiome. Adequate vitamin D status has a beneficial effect on gut microbiota, therefore preventing the progression of MetSyn. Further, well-controlled studies are needed for a better understanding of the mechanisms of action involving vitamin D and microbiota in the pathogenesis of cardiometabolic diseases. MDPI 2023-01-04 /pmc/articles/PMC9866669/ /pubmed/36674452 http://dx.doi.org/10.3390/ijms24020940 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Sukik, Ayah Alalwani, Joud Ganji, Vijay Vitamin D, Gut Microbiota, and Cardiometabolic Diseases—A Possible Three-Way Axis |
title | Vitamin D, Gut Microbiota, and Cardiometabolic Diseases—A Possible Three-Way Axis |
title_full | Vitamin D, Gut Microbiota, and Cardiometabolic Diseases—A Possible Three-Way Axis |
title_fullStr | Vitamin D, Gut Microbiota, and Cardiometabolic Diseases—A Possible Three-Way Axis |
title_full_unstemmed | Vitamin D, Gut Microbiota, and Cardiometabolic Diseases—A Possible Three-Way Axis |
title_short | Vitamin D, Gut Microbiota, and Cardiometabolic Diseases—A Possible Three-Way Axis |
title_sort | vitamin d, gut microbiota, and cardiometabolic diseases—a possible three-way axis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866669/ https://www.ncbi.nlm.nih.gov/pubmed/36674452 http://dx.doi.org/10.3390/ijms24020940 |
work_keys_str_mv | AT sukikayah vitamindgutmicrobiotaandcardiometabolicdiseasesapossiblethreewayaxis AT alalwanijoud vitamindgutmicrobiotaandcardiometabolicdiseasesapossiblethreewayaxis AT ganjivijay vitamindgutmicrobiotaandcardiometabolicdiseasesapossiblethreewayaxis |